Gulf countries such as Saudi Arabia and the UAE dominate the regional market, supported by government-funded healthcare and lifestyle disease management initiatives
Limitations include that the data came from 1 health system in the US, most patients were white, and it was unknown why patients were prescribed this medication, although 93% were diabetic
What Clinical Trials Reveal Large randomized trials and meta-analyses have confirmed semaglutides cholesterol benefits: Total cholesterol: down 46% LDL cholesterol: down about 5% Triglycerides: down 1518% HDL cholesterol: small increase The landmark trial found that semaglutide reduced the risk of heart attack, stroke, or cardiovascular death by about 20%
Instead of causing sharp spikes, it leads to a sustained, unnatural elevation of baseline GH levels
Saito S, Cao DY, Okuno A, Li X, Peng Z, Kelel M, Tsuji NM